Topical Pain Relief Market Report On Competitive Landscape, Key Players, Future Developments & Growth 2025
Topical Pain Relief Market Provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.
Dallas, United States – May 18, 2021 /MarketersMedia/ —
Summary:
The global market for topical pain management drugswas valued at REDACTED in 2019. The market is expected to growat a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED by 2025. Growth of the global market is attributed to factors such as the growing prevalence of cancer, diabetes and other chronic diseases; and strong investment in research and development activities by keymarket players including GlaxoSmithKline, SanofiS.A., Johnson& Johnson, SunPharmaceutical Industries Ltd. and TevaPharmaceutical Industries Ltd., among others.
Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/5870367
The increasing incidence of acute and chronic pain and rising geriatric populationswith osteoporosisrelated issues are the major factors likely to fuel the market for topical pain management drugs.
According to the Global Burden of Disease Study 2016, the high prominence of pain and pain-related diseases is the leading cause of disability and disease burden globally. In 2016, the burden of chronic pain increased,with 1.9 billion peoplewith symptomatic chronic conditions. The burden of chronic pain is likely to drive the market for topical pain management drugs during the forecast period.
The global topical pain management drugsmarket is segmented based on therapeutic class,mode of purchase and region.
Report Scope:
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for topical pain management drugs. The geographical scope of this study is global. Opioid and non-opioid topical pain relief drugs have been analyzed in the report, and types of pain, treatment guidelines and demand for addressing different types of pain have been included in the scope of the study. The market size estimates include both branded and generic drugs.
This report details market shares of topical pain management drugs based on therapeutic class, mode of purchase and geography.
Based on therapeutic class, the market is segmented into non-opioids and opioids. Non-opioids are further segmented into nonsteroidal anti-inflammatory drugs (NSAIDS), capsaicin, lidocaine and others.
Based on mode of purchase, the market is segmented into over-the-counter (OTC) and prescription drugs.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data have been provided for 2019 as the base year, with forecasts for 2020 through 2025. Estimated values are based on drug manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Access Complete Report @ https://www.orbisresearch.com/reports/index/topical-pain-relief-market
Report Includes:
– 29 data tables and 21 additional tables
– An overview of the global topical pain relief market
– Analyses of the global market trends, with data from 2019 and 2020, and projections of compound annual growth rates (CAGRs) through 2025
– Comprehensive analysis of the current and future market potential of topical pain management drugs
– Examination of the competitive environment, regulatory scenario and technological advancements which are influencing the growth of generic drugs market
– Assessment of long-term versus short-term impact of the COVID-19 pandemic on the global topical pain relief market compared to overall pharmaceuticals industry
– Competitive landscape analysis of the key players in the global topical pain relief market and pipeline of select topical pain management drugs
– Key M&A deals, collaborations, agreements, partnerships, and joint ventures within the global topical pain treatment market
– Profiles of the leading market players, including GlaxoSmithKline, Sanofi S.A., Johnson & Johnson, Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
For Enquiry before buying report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/5870367
Companies Mentioned:
ADVACARE PHARMA
ENDO INTERNATIONAL PLC
GLAXOSMITHKLINE
GRUNENTHAL GMBH
JOHNSON & JOHNSON
RECKITT BENCKISER GROUP PLC
SANOFI
SUN PHARMACEUTICAL INDUSTRIES LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TOPICAL BIOMEDICS
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbisresearch
Address: 4144 North Central Expressway, Dallas, TX, United States
Website: https://www.orbisresearch.com/reports/index/topical-pain-relief-market
Source: MarketersMedia
Release ID: 89016124
Copyright © 1999-2013 SproutNews.com
